Billionaire Chris Rokos is Selling These 5 Stocks in 2023
In this article, we discuss billionaire Chris Rokos is selling these 5 stocks in 2023.
Posts Tagged ‘NASDAQ:RXDX’
What Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Mid-Cap Healthcare Stocks To Buy Now
In this article, we discuss 5 best mid-cap healthcare stocks to buy now.
Positive Clinical Trial Results Pushed Prometheus Biosciences (RXDX) in Q4
Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” fourth quarter investor letter. A copy of the same can be downloaded here.
5 Best Performing Biotech Stocks in 2022
Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory...
12 Best Multibagger Stocks to Buy Now
In this uncertain market backdrop, investors are focused on macroeconomic and geopolitical constraints and their potential effects on investment portfolios.
5 Best Small-Cap Stocks To Buy Now
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a California-based surgical robotics company that develops transformative solutions in urology.
5 Best IPO Stocks to Invest In Right Now
In this piece, we will take a look at the five best stocks that have recently had their initial public offering.
5 Biotech Stocks to Buy Today According to Kerr Neilson’s Platinum Asset Management
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
5 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 5 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
10 Small-Cap Stocks to Buy According to ‘Australia’s Warren Buffett’ Kerr Neilson
In this article, we discuss the 10 small-cap stocks to buy according to Australian billionaire Kerr Neilson.
Should I Buy Prometheus Biosciences, Inc. (RXDX)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
13G Filing: Cormorant Asset Management and Ignyta Inc. (RXDX)
Please follow Cormorant Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Cormorant Asset Management or update...
Opus Point Partners’ AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
32 Major Stories Summarizing What’s Happening in the World of Finance Today
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
13G Filing: Cephalon Inc and Ignyta Inc. (NASDAQ:RXDX)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Is Ignyta Inc (RXDX) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Ignyta Inc. (RXDX): Great Point Partners Reports New Stake
In a recent 13G filing with the US SEC, Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 2.05 million shares of Ignyta Inc.
One Vehicle-Repair Giant and Two Biotech Companies with Clusters of Insider Buying
The insider trading activity decreased quite significantly last week as compared to the activity observed during the previous one, partially owing to the four-day workweek.
Is Ignyta Inc (RXDX) A Good Stock To Buy?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Healthcare-Focused Investor Believes These Three Cheap Stocks are Poised to Explode
September was one of the worst periods for healthcare stocks and the returns of healthcare-focused investors suffered a lot amid an 11% drop in the NASDAQ Biotech ETF (IBB) and...
Foresite Capital Betting It All On These Four Healthcare Stocks
Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held...
Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains
Kevin Kotler's Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).
